Copyright © 2003 by the European Society of Cardiology.
Relationship between transcardiac gradient of endothelin-1 and left ventricular remodelling in patients with first anterior myocardial infarction
First Department of Internal Medicine, Shiga University of Medical Science, Seta-Tsukinowa,Otsu 520-2192, Japan
Received May 23, 2002;
accepted June 12, 2002
* Corresponding author. Tel.: +81-775-48-2213; fax: +81-775-43-5839
tutamoto{at}belle.shiga-med.ac.jp
Aims To evaluate whether plasma endothelin-1 (ET-1) is extracted or produced through the heart in patients with acute myocardial infarction (AMI), and the relationship between transcardiac extraction of plasma ET-1 and left ventricular (LV) remodelling.
Methods and results We measured the plasma level of ET-1 in the aortic root (Ao) and coronary sinus (CS) in 48 consecutive patients, who received successful revascularization and enalapril, for a first anterior AMI. In the acute phase the plasma ET-1 level was significantly higher both in the Ao and the CS compared to the control subjects. However, the plasma ET-1 level was significantly lower in the CS than in the Ao in the acute phase and after 1 month. There were significant correlations between transcardiac extraction of ET-1 in the acute phase and LV ejection fraction and LV end-diastolic volume index (LVEDVI) after 1 month. Stepwise multivariate analysis showed that maximal creatine phosphokinase and transcardiac extraction of plasma ET-1 during the acute phase were independently and positively correlated with the absolute change in LVEDVI after 1 month.
Conclusions These results indicate that elevated circulating ET-1 is extracted through the heart in patients with a first anterior AMI and that the extracted ET-1 plays a significant role in modulating post-infarct LV remodelling.
Key Words: Acute myocardial infarction Endothelin-1 Brain natriuretic peptide Ventricular remodelling
![]()
CiteULike
Connotea
Del.icio.us What's this?
Related articles in EHJ:
- The role of the endothelin system in myocardial infarctionnew therapeutic targets?
- R Berger and R Pacher
EHJ 2003 24: 294-296.[Extract] [Full Text]
This article has been cited by other articles:
![]() |
G. Niccoli, G. A. Lanza, S. Shaw, E. Romagnoli, D. Gioia, F. Burzotta, C. Trani, M. A. Mazzari, R. Mongiardo, M. De Vita, et al. Endothelin-1 and acute myocardial infarction: a no-reflow mediator after successful percutaneous myocardial revascularization Eur. Heart J., August 1, 2006; 27(15): 1793 - 1798. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. Khan Role of Endothelin-1 in Acute Myocardial Infarction Chest, May 1, 2005; 127(5): 1474 - 1476. [Full Text] [PDF] |
||||

